Security Reportsbreadcrumb chevronbreadcrumb chevron
Galmed Pharmaceuticals

Galmed Pharmaceuticals

Aramchol is an investigational drug being developed by Galmed Pharmaceuticals as a first-in-class, potentially disease modifying treatment for nonalcoholic steatohepatitis, or NASH, a more advanced condition of non-alcoholic fatty liver disease.Aramchol, a conjugate of Cholic acid and Arachidic acid, is a first in class member of a novel family of synthetic Fatty-Acid/Bile-Acid Conjugates (FABACs). FABACs are composed of endogenic compounds, orally administrated with potentially good safety and tolerability parameters.Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to significantly reduce liver fat content as well as improve metabolic parameters associated with fatty liver disease. UpGuard continuously monitors the security posture of Galmed Pharmaceuticals using open-source, commercial, and proprietary threat intelligence feeds. Our analysis is centered on objective, externally verifiable information.

Galmed Pharmaceuticals Security Rating

${grade.letter}
${publicScore}
${cstarScore}
/ 950
Galmed Pharmaceuticals's security rating is based on the analysis of their external attack surface. The higher the rating, the better their security posture. Start a free trial to get a more in-depth risk assessment for Galmed Pharmaceuticals.
Company
Galmed Pharmaceuticals
Employees
Location
CEO
Last updated
Last updated
Industries
Last updated today

Galmed Pharmaceuticals Vendor Risk Report

This vendor risk report is based on UpGuard’s continuous monitoring of Galmed Pharmaceuticals's security posture using open-source, commercial, and proprietary threat intelligence feeds. The results are summarized into a security rating based on the analysis of hundreds of individual checks across five risk categories: website security, email security, phishing & malware, brand & reputation risk, and network security.

Last updated today

Galmed Pharmaceuticals Data Breaches, Cybersecurity Incidents and News

Security incidents, news, and data leaks relating to Galmed Pharmaceuticals.

#1 Third Party & Supplier Risk Management Software

See how UpGuard shapes up against other platforms in the market.
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan rating
Want a complete vendor risk report on this company?
Our comprehensive vendor risk report is based on this company's external attack surface and provides actionable insights, industry benchmarking, and historical trends.